1
|
Fu C, Brand HS, Bikker FJ. The applications of carbon dots in oral health: A scoping review. Oral Dis 2024; 30:1861-1872. [PMID: 37530494 DOI: 10.1111/odi.14702] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Revised: 07/12/2023] [Accepted: 07/18/2023] [Indexed: 08/03/2023]
Abstract
OBJECTIVES This scoping review aims to provide an overview of the research and potential applications of carbon dots (CDs) for oral health purposes. DESIGN Systematic literature searches were performed on PubMed and Web of Science databases (up to February 2023). Two co-authors selected the published works independently and extracted the data in accordance with the PRISMA statement. Studies with the application of CDs for oral health purposes were included. RESULTS Among 152 articles, 19 articles were finally selected. Eight studies investigated the anti-microbial effects of CDs against, for example, oral pathogens, eight studies explored the applicability of CDs in relation to oral cancer, and three studies investigated CDs in relation to cell differentiation and tissue regeneration in oral health. The studies showed the promising potential of CDs in oral health, particularly for inducing bacterial killing by increasing reactive oxygen species, killing oral cancer cells via photodynamic therapeutic effects, and inducing dental pulp and periodontal bone regeneration. CONCLUSION The findings show that CDs have the potential to be utilized in the future for various oral health purposes. Besides, these results underline the broad-spectrum applicability of CDs, crossing the borders of oral health.
Collapse
Affiliation(s)
- Cuicui Fu
- Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam (UvA) and Vrije Universiteit Amsterdam (VU), Amsterdam, The Netherlands
| | - Henk S Brand
- Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam (UvA) and Vrije Universiteit Amsterdam (VU), Amsterdam, The Netherlands
| | - Floris J Bikker
- Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam (UvA) and Vrije Universiteit Amsterdam (VU), Amsterdam, The Netherlands
| |
Collapse
|
2
|
Deng X, Zhang M, Wang Y, Li C, Zhang X, Weng S, Li Y. Carbon dots with selective fluorescence response to hydroxyl radical for sensitive detection of bleomycin. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2024; 306:123582. [PMID: 37939579 DOI: 10.1016/j.saa.2023.123582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Revised: 10/19/2023] [Accepted: 10/26/2023] [Indexed: 11/10/2023]
Abstract
In this work, antioxidant carbon dots (ACDs) with high quantum yield (63.98%) were developed through a one-step strategy using citric acid, ethylenediamine, and L-arginine as sources. The ACDs demonstrated excellent in vitro antioxidant activity. Additionally, ACDs displayed a unique fluorescence response to hydroxyl radical (OH). Leveraging this distinctive feature, a selective and sensitive fluorescence-based sensor was developed for detecting bleomycin (BLM) in the presence of ferrous ions (Fe2+). The studies on the oxidizing properties and dynamic quenching mechanism of ACDs by OH suggested that OH reduced the contents of the amino and hydroxyl groups of ACDs, leading to a decreased electron cloud density of ACDs for dynamic quenching of ACDs. Under optimally refined conditions, the detection limit of this strategy for BLM was 0.58 μg/mL, with a linear range spanning from 1 to 24 μg/mL when employing ACDs as the probe. This fluorescence sensing strategy provides a promising method for the detection of BLM in clinical samples.
Collapse
Affiliation(s)
- Xiaoqin Deng
- Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Menghan Zhang
- Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Yao Wang
- Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Congpei Li
- Department of Emergency, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
| | - Xintian Zhang
- Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China
| | - Shaohuang Weng
- Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
| | - Yiming Li
- Department of Emergency, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China; National Regional Medical Center, Binhai Campus of the First Affiliated Hospital of Fujian Medical University, Fuzhou 350212, China.
| |
Collapse
|
3
|
Li S, Wang Q, Jia Z, Da M, Zhao J, Yang R, Chen D. Recent advances in glucose oxidase-based nanocarriers for tumor targeting therapy. Heliyon 2023; 9:e20407. [PMID: 37780773 PMCID: PMC10539972 DOI: 10.1016/j.heliyon.2023.e20407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Revised: 09/21/2023] [Accepted: 09/22/2023] [Indexed: 10/03/2023] Open
Abstract
Glucose oxidase (GOx) can specifically catalyze the conversion of β-d-glucose into gluconic acid and hydrogen peroxide (H2O2) in the presence of oxygen, making it promising for tumor starvation therapy and oxidative therapy. However, GOx's immunogenicity, poor in vivo stability, short half-life, and potential systemic toxicity, limit its application in cancer therapy. Nanocarriers are capable of improving the pharmacological properties of therapeutic drugs (e.g. stability, circulating half-life, and tumor accumulation) and lower toxicity, hence resolving GOx issues and enhancing its efficacy. Although the application of targeted nanocarriers based on GOx has recently flourished, this field has not yet been reviewed and evaluated. Herein, we initially examined the mechanism of GOx-based nanocarriers for enhanced tumor therapy. Also, we present a comprehensive and up-to-date review that highlights GOx-based nanocarriers for tumor targeting therapy. This review expands on GOx-based nano-targeted combination therapies from both passive and active targeting perspectives, meanwhile, active targeting is further classified into ligand-mediated targeting and physical-mediated targeting. Furthermore, this review also emphasizes the present challenges and promising advancements.
Collapse
Affiliation(s)
- Su Li
- Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Hospital of Nanjing Medical University, Wuxi, 214002, China
| | - Qinghua Wang
- Wuxi Maternal and Child Health Hospital, Wuxi School of Medicine, Jiangnan University, Jiangsu, 214002, China
| | - Zhen Jia
- Department of Obstetrics and Gynecology, Haidong No. 2 People's Hospital, Haidong, 810699, China
| | - Mengting Da
- Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University and Affiliated Cancer Hospital of Qinghai University, Xining, 810001, China
| | - Jiuda Zhao
- Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University and Affiliated Cancer Hospital of Qinghai University, Xining, 810001, China
| | - Rui Yang
- Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Hospital of Nanjing Medical University, Wuxi, 214002, China
| | - Daozhen Chen
- Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Hospital of Nanjing Medical University, Wuxi, 214002, China
- Department of Obstetrics and Gynecology, Haidong No. 2 People's Hospital, Haidong, 810699, China
| |
Collapse
|
5
|
He C, Lin X, Mei Y, Luo Y, Yang M, Kuang Y, Yi X, Zeng W, Huang Q, Zhong B. Recent Advances in Carbon Dots for In Vitro/Vivo Fluorescent Bioimaging: A Mini-Review. Front Chem 2022; 10:905475. [PMID: 35601546 PMCID: PMC9117726 DOI: 10.3389/fchem.2022.905475] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2022] [Accepted: 04/20/2022] [Indexed: 12/13/2022] Open
Abstract
As a new type of “zero-dimensional” fluorescent carbon nanomaterials, carbon dots (CDs) have some unique optical and chemical properties, they are being explored for a variety of applications in bio-related fields, such as bioimaging, biosensors, and therapy. This review mainly summarizes the recent progress of CDs in bioimaging. The overview of this review can be roughly divided into two categories: (1) In vitro bioimaging based on CDs in different cells and important organelles. (2) The distribution, imaging and application of CDs in mice and zebrafish. In addition, this review also points out the potential advantages and future development directions of CDs for bioimaging, which may promote the development of CDs in the field of bioimaging.
Collapse
Affiliation(s)
- Chen He
- Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, China
- School of Pharmacy, Gannan Medical University, Ganzhou, China
| | - Xiaofeng Lin
- Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, China
- School of Pharmacy, Gannan Medical University, Ganzhou, China
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
- *Correspondence: Xiaofeng Lin, ; Weijia Zeng, ; Qitong Huang, ; Bin Zhong,
| | - Yanqiu Mei
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
| | - Yan Luo
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
| | - Min Yang
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
| | - Ying Kuang
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
| | - Xiaoqing Yi
- Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, China
- School of Pharmacy, Gannan Medical University, Ganzhou, China
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
| | - Weijia Zeng
- Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, China
- School of Pharmacy, Gannan Medical University, Ganzhou, China
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
- *Correspondence: Xiaofeng Lin, ; Weijia Zeng, ; Qitong Huang, ; Bin Zhong,
| | - Qitong Huang
- Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, China
- School of Pharmacy, Gannan Medical University, Ganzhou, China
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
- *Correspondence: Xiaofeng Lin, ; Weijia Zeng, ; Qitong Huang, ; Bin Zhong,
| | - Bin Zhong
- Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, China
- School of Pharmacy, Gannan Medical University, Ganzhou, China
- Key Laboratory of Biomedical Sensors of Ganzhou, Ganzhou Key Laboratory of Immunotherapeutic Drugs Developing for Childhood Leukemia, Key Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, School of Medical and Information Engineering, School of Public Health and Health Management, Oil-Tea in Medical Health Care and Functional Product Development Engineering Research Center in Jiangxi, Gannan Medical University, Ganzhou, China
- *Correspondence: Xiaofeng Lin, ; Weijia Zeng, ; Qitong Huang, ; Bin Zhong,
| |
Collapse
|